97 related articles for article (PubMed ID: 3401892)
1. [Hemodynamic effects of isosorbide-5-mononitrate in ischemic cardiopathy].
Russo G; Tolaro S; Monaco O; Greco G; Grassi R; Monaco A; Calvi V; Felis S; Tamburino C; Giuffrida G
Cardiologia; 1988 Mar; 33(3):291-5. PubMed ID: 3401892
[No Abstract] [Full Text] [Related]
2. [Isosorbide-5-mononitrate. Hemodynamic studies during subchronic therapy].
Wiechmann HW; Schuster P; Trieb G
Med Welt; 1983 Jul; 34(27):765-7. PubMed ID: 6888248
[No Abstract] [Full Text] [Related]
3. [Long-term tolerance and effect of isosorbide-5-mononitrate in comparison to isosorbide dinitrate (ISDN retard) in patients with coronary disease].
Smolarz A; Seeliger S; Glocke M
Med Welt; 1981 Apr; 32(14A):548-53. PubMed ID: 6787385
[No Abstract] [Full Text] [Related]
4. Acute effect of various doses of isosorbide-5-mononitrate on hemodynamic and exercise performance in coronary artery disease.
Jansen W; Meyer L; Tauchert M
Am J Cardiol; 1988 Mar; 61(9):31E-35E. PubMed ID: 3348138
[TBL] [Abstract][Full Text] [Related]
5. Hemodynamic effects of oral isosorbide-5-mononitrate and dinitrate in ischemic heart failure.
Rabinowitz B; Hod H; Chouraqui P; Rath S; Agranat O; Neufeld HN
Clin Cardiol; 1987 Oct; 10(10):603-8. PubMed ID: 3665218
[TBL] [Abstract][Full Text] [Related]
6. [Hemodynamic changes at rest and during stress following isosorbide-5-mononitrate therapy in patients with coronary disease].
Isbary J; Doering W; Wauer B; Greding H; König E
Med Welt; 1981 Apr; 32(14A):530-4. PubMed ID: 7242315
[No Abstract] [Full Text] [Related]
7. [Hemodynamic effect of 20 mg and 50 mg of 5-isosorbide mononitrate in acute and chronic therapy].
Jansen W; Osterspey A; Fuchs M; Tauchert M; Schell U; Weste S; Hombach V
Med Welt; 1982 Dec; 33(48):1756-62. PubMed ID: 6818416
[No Abstract] [Full Text] [Related]
8. Hemodynamic effects of isosorbide-5-mononitrate in acute and chronic treatment of coronary heart disease.
Schuster P; Trieb G; Wiechmann HW
Z Kardiol; 1983; 72 Suppl 3():251-4. PubMed ID: 6666229
[TBL] [Abstract][Full Text] [Related]
9. [Effect of isosorbide-5-mononitrate (IS-5-MN) on left ventricular hemodynamics].
Mehmel HC; Ruffmann K; Schwarz F; Manthey J; Kübler W
Med Welt; 1981 Apr; 32(14A):527-9. PubMed ID: 7242314
[No Abstract] [Full Text] [Related]
10. Antianginal and anti-ischemic efficacy of nicorandil in comparison with isosorbide-5-mononitrate and isosorbide dinitrate: results from two multicenter, double-blind, randomized studies with stable coronary heart disease patients.
Döring G
J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S74-81. PubMed ID: 1282180
[TBL] [Abstract][Full Text] [Related]
11. Comparative clinical trial of isosorbide 5-mononitrate and sustained-release isosorbide dinitrate in ischaemic heart disease.
Neuhaus R; Johnen R; Vydra L; Solbach C
Pharmatherapeutica; 1986; 4(8):486-95. PubMed ID: 3086899
[TBL] [Abstract][Full Text] [Related]
12. [Effect of isosorbide dinitrate (isoket) on central hemodynamics and myocardial contraction in patients with ischemic heart disease].
Abugov AM; Flerov EV; Tkachenko VM; Iavorovskiĭ AG; Shchepkin VA
Kardiologiia; 1984 Nov; 24(11):96-100. PubMed ID: 6521215
[TBL] [Abstract][Full Text] [Related]
13. Effect of lisinopril and isosorbide-5-mononitrate on hemodynamics and mortality in rats with permanent coronary artery occlusion.
Riva E; Kurosaki M; Latini R
J Cardiovasc Pharmacol; 1992 Sep; 20(3):490-5. PubMed ID: 1279297
[TBL] [Abstract][Full Text] [Related]
14. Hemodynamic effects of oral and sublingual forms of isosorbide dinitrate in patients with acute coronary insufficiency.
Poliner LR; Ritter W; Wohl AJ; Nixon JV; Willerson JT
Tex Med; 1977 Feb; 73(2):53-8. PubMed ID: 841487
[No Abstract] [Full Text] [Related]
15. [Elantan in coronary heart disease. Report of experiences].
Jahed M
ZFA (Stuttgart); 1983 Aug; 59(22):1234-5. PubMed ID: 6624210
[No Abstract] [Full Text] [Related]
16. [The association of amlodipine with isosorbide-5-mononitrate in the treatment of ischemic-hypertensive cardiopathy].
Palazzuoli V; Mondillo S; Faglia S; D'Aprile N; Kristodhullo A
Clin Ter; 1992 Jul; 141(7):9-14. PubMed ID: 1387055
[TBL] [Abstract][Full Text] [Related]
17. [Delayed-action isosorbide-5-mononitrate preparations--are there differences in the acute effect?].
Jansen W; Geppert R; Weidmann B; Tauchert M
Med Klin (Munich); 1987 Nov; 82(24):854-9. PubMed ID: 3431518
[No Abstract] [Full Text] [Related]
18. [Hemodynamic effects of isosorbide-5-mononitrate in coronary heart disease. A comparison of acute and chronic treatment].
Wiechmann HW; Schuster P; Trieb G
Dtsch Med Wochenschr; 1983 Sep; 108(35):1304-7. PubMed ID: 6884214
[TBL] [Abstract][Full Text] [Related]
19. Nitrate tolerance: hemodynamic effects of intravenous isosorbide dinitrate after sustained oral isosorbide dinitrate administration.
Kumagae H; Koiwaya Y; Tanaka K
Clin Ther; 1990; 12(1):31-43. PubMed ID: 2328526
[TBL] [Abstract][Full Text] [Related]
20. [Left ventricular function parameters following administration of isosorbide-5-mononitrate].
Bergbauer M
Med Welt; 1983 Jun; 34(22):642-4. PubMed ID: 6877071
[No Abstract] [Full Text] [Related]
[Next] [New Search]
